TWiV 870: COVID-19 clinical update #103 with Dr. Daniel Griffin
Feb 26, 2022•44 min•Ep. 870
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #102, Daniel Griffin covers immunocompromised people, hospitalization of children, vaccine usage update, Omicron and cross-reactive neutralizing antibodies, reinfection prevents disease in hamsters, repeated infections with endemic coronaviruses, global burden of antimicrobial resistance, ivermectin not protective in hamsters, and Omicron evades therapeutic monoclonals.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- What does society owe immunocompromised people (Atlantic)
- Prevalence of immunosuppression in US (JAME)
- Hospitalizations of children (MMWR)
- Clinical considerations for vaccines (CDC)
- Sanofi seeks vaccine approval (Sanofi)
- Omicron triggers cross-reactive neutralization (medRxiv)
- Reinfection prevents disease in hamsters (Cell)
- Repeated infections with endemic CoV (J Inf Dis)
- Global burden of antimicrobial resistance (Lancet)
- Ivermectin not protective in hamsters (bioRxiv)
- Omicron evades therapeutic monoclonals (bioRxiv)
- Letters read on TWiV 870
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android